Low-intensity Shockwave Therapy for Post-radical Prostatectomy Erectile Dysfunction

Last updated: October 3, 2024
Sponsor: The Methodist Hospital Research Institute
Overall Status: Terminated

Phase

N/A

Condition

Male Hormonal Deficiencies/abnormalities

Impotence

Erectile Dysfunction

Treatment

Low-Intensity Shockwave therapy (LiSWT)

Clinical Study ID

NCT06219785
Pro00037405
  • Ages 45-70
  • Male

Study Summary

This research study is trying to determine if Low-Intensity shock wave therapy (LiSWT) is safe and effective in patients with symptoms of erectile dysfunction (ED) after radical prostatectomy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Men age 45-70 who had robotic prostatectomy within 6 to 18 months

  2. Documented nerve sparing during radical prostatectomy procedure

  3. Mild to moderate ED after prostatectomy

  4. IIEF score > 18 before surgery

  5. Testosterone level > 300 mg/dl post-surgery

  6. Sexually active

Exclusion

Exclusion Criteria:

  1. Prior penile surgery

  2. Lesions or active infections on the penis or perineum

  3. Anatomical abnormalities in the genitalia or pelvic region

  4. Unwilling to remove piercing from genital region

  5. Post radical prostatectomy complications that could impact safety or effectivenessof ESWT (hematoma, unresolved anastomotic leak)

  6. Previous or scheduled treatment with pelvic radiotherapy and/or androgen deprivationtherapy

  7. Anticoagulant medication (except acetylsalicylic acid up to 80 mg daily).

  8. Any other condition that would prevent the patient from completing the study, asjudged by the PI

Study Design

Total Participants: 5
Treatment Group(s): 1
Primary Treatment: Low-Intensity Shockwave therapy (LiSWT)
Phase:
Study Start date:
January 10, 2024
Estimated Completion Date:
October 01, 2024

Study Description

Participants will be randomized to the active treatment group or the control/placebo group.

All patients on active treatment will receive Low-Intensity shock wave treatment. Participants assigned to the control group will receive the treatment using a sham applicator. The placebo group will receive the same treatment as the active group, but the transducer used for shock wave treatment will be capped, meaning that no shock waves will be transmitted to the penis.

Participants on active shock wave treatment will receive once a week Low-Intensity shock wave treatments of 0.2 mJ/ mm² over the lateral penile shaft (distal, mid, and proximal penile shaft), 500 impulses in each area, for a total of 1500 shocks along the penis once a week for six weeks, with a total of 6 treatments once a week.

Connect with a study center

  • Houston Methodist

    Houston, Texas 77030
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.